GENE ONLINE|News &
Opinion
Blog

Non-Hodgkin Lymphoma
Trials & Approvals Roche
Roche’s Non-Hodgkin Lymphoma Drug Could See Accelerated Approval By December
2022-07-07
Asia-Pacific CAR T-cell TherapyB-cell Lymphoma
Daiichi Sankyo Authorizes First Yescarta Treatment Site in Japan
2021-12-17
Cancer
Samsung Biologics Renews Manufacturing Deal to Expand Production of TG Therapeutics’ Cancer Drug
2021-04-27
Trials & Approvals CAR T-cell Therapy
Gilead’s Breakthrough CAR-T Becomes First to Get FDA Approval for Indolent Follicular Lymphoma
2021-03-07
Trials & Approvals Non-Hodgkin Lymphoma
FDA Greenlights Pfizer’s Xalkori for a Rare Form of Non-Hodgkin Lymphoma
2021-01-19
R&D
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
R&D
ASH2020: New Studies Showcase Potential of CAR-T Therapy to Treat More Cancers
2020-12-07
Trials & Approvals
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
R&D CRISPR
CRISPR Therapeutics’ CAR-T Cell Therapy Registers Mixed Results in Cancer Trial
2020-10-23
Trials & Approvals Non-Hodgkin Lymphoma
Chinese Biopharma Makes Potential Headway Against Unique Type of Non-Hodgkin Lymphoma
2020-09-06
Trials & Approvals Follicular Lymphoma
Novartis’ Kymriah Headed Towards Third Approval for Follicular Lymphoma
2020-08-06
R&D
Polivy – A New and Improved Arsenal from Roche to Fight DLBCL Relapse
2020-01-24
LATEST
What is Tech Giant NVIDIA Doing Now? Latest Collabs Building the Healthcare Puzzle, One Byte at a Time
2025-01-15
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
Asia Microbiome Conference Reached a New Milestone: From Innovative Forum to Microbiome Carnival
2025-01-15
The Impact of “Inner Excellence” on A.J. Brown’s Performance and Mindset
2025-01-14
Menarini Group and Insilico Medicine Enter a Second Exclusive Global License Agreement for an AI Discovered Preclinical Asset Targeting High Unmet Needs in Oncology
2025-01-10
United Imaging Announces Major Expansion of U.S. Manufacturing Space
2025-01-09
Posdinemab Becomes J&J’s Second FDA Fast Track Designation Targeting Phosphorylated Tau in Alzheimer’s Disease
2025-01-09
READ MORE
EVENT
2025-01-13
Biotech Showcase 2025
San Francisco, California
2025-01-13
JP Morgan Healthcare Conference
San Francisco, California
2025-02-05
Precision Medicine World Conference 2025
Santa Clara, California
2025-02-19
Healthcare Conference Taipei 2025
Taipei, Taiwan
2025-03-17
BIO-Europe Spring 2025
Milan, Italy
2025-04-02
Asia Cell and Gene Therapy Innovation Summit 2025
Shanghai, China
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top